{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:38:32Z","timestamp":1781015912500,"version":"3.54.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T00:00:00Z","timestamp":1390608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00213-014-3449-x","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T07:19:30Z","timestamp":1390547970000},"page":"2741-2750","source":"Crossref","is-referenced-by-count":18,"title":["Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users"],"prefix":"10.1007","volume":"231","author":[{"given":"Katherine R.","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Lile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Stoops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,25]]},"reference":[{"key":"3449_CR1","first-page":"45","volume":"44","author":"DR Abernethy","year":"1983","unstructured":"Abernethy DR, Greenblatt DJ, Divoll M et al (1983) Pharmacokinetics of alprazolam. J Clin Psychiatry 44:45\u201347","journal-title":"J Clin Psychiatry"},{"key":"3449_CR2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ar.a.20054","volume":"279","author":"LM Ambrose","year":"2004","unstructured":"Ambrose LM, Unterwald EM, Van Bockstaele EJ (2004) Ultrastructural evidence for co-localization of dopamine D2 and mu-opioid receptors in the rat dorsolateral striatum. Anat Rec 279:583\u2013591","journal-title":"Anat Rec"},{"key":"3449_CR3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0006-3223(87)90070-9","volume":"22","author":"B Angrist","year":"1987","unstructured":"Angrist B, Corwin J, Bartlik B, Cooper T (1987) Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol Psychiatry 22:1357\u20131368","journal-title":"Biol Psychiatry"},{"key":"3449_CR4","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, Ciraulo DA et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study. A randomized controlled trial. JAMA 295:2003\u20132017","journal-title":"JAMA"},{"key":"3449_CR5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1124\/jpet.105.086033","volume":"315","author":"AC Barrett","year":"2005","unstructured":"Barrett AC, Negus SS, Mello NK, Caine SB (2005) Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food-maintained responding and cocaine discrimination in rats. J Pharmacol Exp Ther 315:858\u2013871","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 5","key":"3449_CR6","first-page":"7","volume":"65","author":"G Chouinard","year":"2004","unstructured":"Chouinard G (2004) Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 65(Suppl 5):7\u201312","journal-title":"J Clin Psychiatry"},{"key":"3449_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00966870","volume":"17","author":"L Churchill","year":"1992","unstructured":"Churchill L, Dilts RP, Kalivas PW (1992) Autoradiographic localization of gamma-aminobutyric acid receptors within the ventral tegmental area. Neurochem Res 17:101\u2013106","journal-title":"Neurochem Res"},{"key":"3449_CR8","doi-asserted-by":"crossref","unstructured":"Comer SD, Mogali S, Saccone PA et al (2013) Effects of acute oral naltrexone on the subjective physiological effects of oral d-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology 38:2427\u20132438","DOI":"10.1038\/npp.2013.143"},{"key":"3449_CR9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0028-3908(78)90031-X","volume":"17","author":"PW Dettmar","year":"1978","unstructured":"Dettmar PW, Cowan A, Walter DS (1978) Naloxone antagonizes behavioural effects of d-amphetamine in mice and rats. Neuropharmacology 17:1041\u20131044","journal-title":"Neuropharmacology"},{"key":"3449_CR10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W","volume":"25","author":"SL Dewey","year":"1997","unstructured":"Dewey SL, Chaurasia CS, Chen CE et al (1997) GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25:393\u2013398","journal-title":"Synapse"},{"key":"3449_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0376-8716(02)00065-0","volume":"67","author":"RN Ehrman","year":"2002","unstructured":"Ehrman RN, Robbins SJ, Bromwell MA, Lankford ME, Monterosso JR, O\u2019Brien CP (2002) Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug Alcohol Depend 67:185\u2013191","journal-title":"Drug Alcohol Depend"},{"key":"3449_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08897070802218554","volume":"29","author":"A Elkashef","year":"2008","unstructured":"Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J (2008) Pharmacotherapy of methamphetamine addiction: an update. Subst Abuse 29:31\u201349","journal-title":"Subst Abuse"},{"key":"3449_CR13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/11588190-000000000-00000","volume":"31","author":"JC Ermer","year":"2011","unstructured":"Ermer JC, Dennis K, Haffey MB et al (2011) Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult men. Clin Drug Investig 31:357\u2013370","journal-title":"Clin Drug Investig"},{"key":"3449_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0376-8716(03)00089-9","volume":"71","author":"MT Fillmore","year":"2003","unstructured":"Fillmore MT, Rush CR, Marczinski CA (2003) Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71:143\u2013152","journal-title":"Drug Alcohol Depend"},{"key":"3449_CR15","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2174\/138161210791516459","volume":"16","author":"JC Garbutt","year":"2010","unstructured":"Garbutt JC (2010) Efficacy and tolerability of naltrexone in the management of alcohol dependence. Curr Pharm Des 16:2091\u20132097","journal-title":"Curr Pharm Des"},{"key":"3449_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.fbp.0000166464.68186.25","volume":"16","author":"MB Gatch","year":"2005","unstructured":"Gatch MB, Selvig M, Forster MJ (2005) GABAergic modulation of the discriminative-stimulus effects of methamphetamine. Behav Pharmacol 16:261\u2013266","journal-title":"Behav Pharmacol"},{"key":"3449_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pbb.2008.07.005","volume":"91","author":"NE Goeders","year":"2008","unstructured":"Goeders NE, Guerin GF (2008) Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats. Pharmacol Biochem Behav 91:181\u2013189","journal-title":"Pharmacol Biochem Behav"},{"key":"3449_CR18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0091-3057(89)90483-8","volume":"33","author":"NE Goeders","year":"1989","unstructured":"Goeders NE, McNulty MA, Mirkis S, McAllister KH (1989) Chlordiazepoxide alters intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 33:859\u2013866","journal-title":"Pharmacol Biochem Behav"},{"key":"3449_CR19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(93)90493-D","volume":"44","author":"NE Goeders","year":"1993","unstructured":"Goeders NE, McNulty MA, Guerin GF (1993) Effects of alprazolam on intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 44:471\u2013474","journal-title":"Pharmacol Biochem Behav"},{"key":"3449_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00003088-199324060-00003","volume":"24","author":"DJ Greenblatt","year":"1993","unstructured":"Greenblatt DJ, Wright CE (1993) Clinical pharmacokinetics of alprazolam. Clin Pharmacokinet 24:453\u2013471","journal-title":"Clin Pharmacokinet"},{"key":"3449_CR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-198308030-00003","volume":"8","author":"DJ Greenblatt","year":"1983","unstructured":"Greenblatt DJ, Divoll M, Abernethy DR et al (1983) Clinical pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 8:233\u2013252","journal-title":"Clin Pharmacokinet"},{"key":"3449_CR22","doi-asserted-by":"crossref","unstructured":"Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV (1985) Relative abuse liability of triazolam: experimental assessment in animals and humans. Neurosci Biobehav Rev 9:133\u2013151","DOI":"10.1016\/0149-7634(85)90039-9"},{"key":"3449_CR23","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0376-8716(03)00098-X","volume":"70","author":"RR Griffiths","year":"2003","unstructured":"Griffiths RR, Bigelow GE, Ator NA (2003) Principles of initial experimental drug abuse liability assessment in humans. Drug Alcohol Depend 70:S41\u2013S54","journal-title":"Drug Alcohol Depend"},{"key":"3449_CR24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1369-1600.2009.00150.x","volume":"14","author":"J Haggkvist","year":"2009","unstructured":"Haggkvist J, Lindholm S, Franck J (2009) The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat. Addict Biol 14:260\u2013269","journal-title":"Addict Biol"},{"key":"3449_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0376-8716(81)90084-3","volume":"8","author":"LE Hollister","year":"1981","unstructured":"Hollister LE, Johnson K, Boukhabza D, Gillespie HK (1981) Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depend 8:37\u201341","journal-title":"Drug Alcohol Depend"},{"key":"3449_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3565(25)29807-X","volume":"189","author":"SG Holtzman","year":"1974","unstructured":"Holtzman SG (1974) Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J Pharmacol Exp Ther 189:51\u201360","journal-title":"J Pharmacol Exp Ther"},{"key":"3449_CR27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0091-3057(92)90027-D","volume":"42","author":"MS Hooks","year":"1992","unstructured":"Hooks MS, Jones DN, Justice JB Jr, Holtzman SG (1992) Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol Biochem Behav 42:765\u2013770","journal-title":"Pharmacol Biochem Behav"},{"key":"3449_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0005-7967(98)00100-4","volume":"37","author":"SA Janssen","year":"1999","unstructured":"Janssen SA, Arntz A (1999) No interactive effects of naltrexone and benzodiazepines on pain during phobic fear. Behav Res Ther 37:77\u201386","journal-title":"Behav Res Ther"},{"key":"3449_CR29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","volume":"24","author":"N Jayaram-Lindstr\u00f6m","year":"2004","unstructured":"Jayaram-Lindstr\u00f6m N, Wennberg P, Hurd YL, Franck J (2004) Effects of naltrexone on the subjective response to amphetamine in healthy volunteers. J Clin Psychopharmacol 24:665\u2013669","journal-title":"J Clin Psychopharmacol"},{"key":"3449_CR30","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","volume":"165","author":"N Jayaram-Lindstr\u00f6m","year":"2008","unstructured":"Jayaram-Lindstr\u00f6m N, Hammarberg A, Beck O, Franck J (2008a) Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Am J Psychiatry 165:1442\u20131448","journal-title":"Am J Psychiatry"},{"key":"3449_CR31","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","volume":"33","author":"N Jayaram-Lindstr\u00f6m","year":"2008","unstructured":"Jayaram-Lindstr\u00f6m N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J (2008b) Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. Neuropsychopharmacology 33:1856\u20131863","journal-title":"Neuropsychopharmacology"},{"key":"3449_CR32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FBP.0b013e3283423d55","volume":"22","author":"C Jimenez-Gomez","year":"2010","unstructured":"Jimenez-Gomez C, Winger G, Dean RL, Deaver DR, Woods JH (2010) Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys. Behav Pharmacol 22:87\u201390","journal-title":"Behav Pharmacol"},{"key":"3449_CR33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1037\/1064-1297.14.2.99","volume":"14","author":"CE Johanson","year":"2006","unstructured":"Johanson CE, Lundahl LH, Lockhard N, Schubiner H (2006) Intravenous cocaine discrimination in humans. Exp Clin Psychopharmacol 14:99\u2013108","journal-title":"Exp Clin Psychopharmacol"},{"key":"3449_CR34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/0269881111430745","volume":"26","author":"AS Kablinger","year":"2012","unstructured":"Kablinger AS, Lindner MA, Casso S et al (2012) Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study. J Psychopharmacol 26:973\u2013981","journal-title":"J Psychopharmacol"},{"key":"3449_CR35","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","volume":"69","author":"L Karila","year":"2010","unstructured":"Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL (2010) Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol 69:578\u2013592","journal-title":"Br J Clin Pharmacol"},{"key":"3449_CR36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1901\/jeab.1994.61-169","volume":"61","author":"RJ Lamb","year":"1994","unstructured":"Lamb RJ, Henningfield JE (1994) Human d-amphetamine drug discrimination: methamphetamine and hydromorphone. J Exp Anal Behav 61:169\u2013180","journal-title":"J Exp Anal Behav"},{"key":"3449_CR37","first-page":"1207","volume":"29","author":"MC Lee","year":"1988","unstructured":"Lee MC, Wagner HN Jr, Tanada S, Frost JJ, Bice AN, Dannals RF (1988) Duration of occupancy of opiate receptors by naltrexone. J Nucl Med 29:1207\u20131211","journal-title":"J Nucl Med"},{"key":"3449_CR38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1037\/1076-898X.8.2.75","volume":"8","author":"CW Lejuez","year":"2002","unstructured":"Lejuez CW, Read JP, Kahler CW et al (2002) Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Taking (BART). J Exp Psychol Appl 8:75\u201384","journal-title":"J Exp Psychol Appl"},{"key":"3449_CR39","doi-asserted-by":"crossref","unstructured":"Lile JA, Stoops WW, Glaser PEA, Hays LR, Rush CR (2011a) Subjective and physiological effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Drug Alcohol Depend 119:187\u2013193","DOI":"10.1016\/j.drugalcdep.2011.06.006"},{"key":"3449_CR40","doi-asserted-by":"crossref","unstructured":"Lile JA, Stoops WW, Glaser PEA, Hays LR, Rush CR (2011b) Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. J Psychopharmacol 25:1469\u20131479","DOI":"10.1177\/0269881110385597"},{"key":"3449_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/00952990.2010.543204","volume":"37","author":"S Liu","year":"2011","unstructured":"Liu S, Lane SD, Schmitz JM, Waters AJ, Cunningham KA, Moeller FG (2011) Relationship between attentional bias to cocaine-related stimuli and impulsivity in cocaine-dependent subjects. Am J Drug Alcohol Abuse 37:117\u2013122","journal-title":"Am J Drug Alcohol Abuse"},{"key":"3449_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/1064-1297.15.2.123","volume":"15","author":"AP Makris","year":"2007","unstructured":"Makris AP, Rush CR, Frederich RC, Taylor AC, Kelly TH (2007) Behavioral and subjective effects of d-amphetamine and modafinil in humans. Exp Clin Psychopharmacol 15:123\u2013133","journal-title":"Exp Clin Psychopharmacol"},{"key":"3449_CR43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","volume":"14","author":"DR McLeod","year":"1982","unstructured":"McLeod DR, Griffiths RR, Bigelow GE, Yingling JE (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 14:463\u2013466","journal-title":"Behav Res Methods Instrum"},{"key":"3449_CR44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","volume":"64","author":"HY Meltzer","year":"2013","unstructured":"Meltzer HY (2013) Update on typical and atypical antipsychotic drugs. Annu Rev Med 64:393\u2013406","journal-title":"Annu Rev Med"},{"key":"3449_CR45","first-page":"15","volume":"45","author":"MC Meyer","year":"1984","unstructured":"Meyer MC, Straughn AB, Lo MW, Schary WL, Whitney CC (1984) Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration. J Clin Psychiatry 45:15\u201319","journal-title":"J Clin Psychiatry"},{"key":"3449_CR46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0009-9236(95)90162-0","volume":"57","author":"GK Mumford","year":"1995","unstructured":"Mumford GK, Evans SM, Fleishaker JC, Griffiths RR (1995a) Alprazolam absorption kinetics affects abuse liability. Clin Pharmacol Ther 57:356\u2013365","journal-title":"Clin Pharmacol Ther"},{"key":"3449_CR47","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3565(25)24438-X","volume":"272","author":"GK Mumford","year":"1995","unstructured":"Mumford GK, Rush CR, Griffiths RR (1995b) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570\u2013580","journal-title":"J Pharmacol Exp Ther"},{"key":"3449_CR48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s002130000543","volume":"152","author":"SS Negus","year":"2000","unstructured":"Negus SS, Mello NK, Fivel PA (2000) Effects of GABA agonists and the GABA-A receptor modulators on cocaine discrimination in rhesus monkeys. Psychopharmacology 152:398\u2013407","journal-title":"Psychopharmacology"},{"key":"3449_CR49","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3565(25)11160-9","volume":"261","author":"AH Oliveto","year":"1992","unstructured":"Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW (1992) Caffeine drug discrimination in humans: acquisition, specificity, and correlation with self-reports. J Pharmacol Exp Ther 261:885\u2013894","journal-title":"J Pharmacol Exp Ther"},{"key":"3449_CR50","first-page":"207","volume":"9","author":"AH Oliveto","year":"1998","unstructured":"Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR (1998) Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav Pharmacol 9:207\u2013217","journal-title":"Behav Pharmacol"},{"key":"3449_CR51","first-page":"66","volume":"67","author":"DN Pfohl","year":"1986","unstructured":"Pfohl DN, Allen JI, Atkinson RL et al (1986) Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage. NIDA Res Monogr 67:66\u201372","journal-title":"NIDA Res Monogr"},{"key":"3449_CR52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neubiorev.2005.04.016","volume":"30","author":"RC Pierce","year":"2006","unstructured":"Pierce RC, Kumaresan V (2006) The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30:215\u2013238","journal-title":"Neurosci Biobehav Rev"},{"key":"3449_CR53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0304-3940(78)90216-1","volume":"7","author":"H Pollard","year":"1977","unstructured":"Pollard H, Llorens C, Bonnet JJ, Costentin J, Schwartz JC (1977) Opiate receptors on mesolimbic dopaminergic neurons. Neurosci Lett 7:295\u2013299","journal-title":"Neurosci Lett"},{"key":"3449_CR54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM et al (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32\u201341","journal-title":"Synapse"},{"key":"3449_CR55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0149-7634(05)80011-9","volume":"17","author":"CR Rush","year":"1993","unstructured":"Rush CR, Higgins ST, Bickel WK, Hughes JR (1993) Abuse liability of alprazolam relative to other commonly used benzodiazepines: a review. Neurosci Biobehav Rev 17:277\u2013285","journal-title":"Neurosci Biobehav Rev"},{"key":"3449_CR56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.102.048439","volume":"306","author":"CR Rush","year":"2003","unstructured":"Rush CR, Stoops WW, Hays LR, Glaser PE, Hays LS (2003) Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306:195\u2013204","journal-title":"J Pharmacol Exp Ther"},{"key":"3449_CR57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.jcp.0000130553.55630.ad","volume":"24","author":"CR Rush","year":"2004","unstructured":"Rush CR, Stoops WW, Wagner FP, Hays LR, Glaser PEA (2004) Alprazolam attenuates the behavioral effects of d-amphetamine in humans. J Clin Psychopharmacol 24:410\u2013420","journal-title":"J Clin Psychopharmacol"},{"key":"3449_CR58","first-page":"335","volume-title":"Pharmacology and treatment of substance abuse: evidence- and outcome-based perspectives","author":"CR Rush","year":"2009","unstructured":"Rush CR, Vansickel AR, Lile JA, Stoops WW (2009) Evidence-based treatment of amphetamine dependence: behavioral and pharmacological approaches. In: Cohen L, Collins FL, Young AM, McChargue DE, Leffingwell TR, Cook KL (eds) Pharmacology and treatment of substance abuse: evidence- and outcome-based perspectives. Routledge, Taylor and Francis Group, New York, pp 335\u2013358"},{"key":"3449_CR59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(94)00726-N","volume":"275","author":"CA Schad","year":"1995","unstructured":"Schad CA, Justice JB Jr, Holtzman SG (1995) Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine. Eur J Pharmacol 275:9\u201316","journal-title":"Eur J Pharmacol"},{"key":"3449_CR60","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/jpet.108.147124","volume":"328","author":"RJ Sevak","year":"2009","unstructured":"Sevak RJ, Stoops WW, Hays LR, Rush CR (2009) Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther 328:1007\u20131018","journal-title":"J Pharmacol Exp Ther"},{"key":"3449_CR61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/FBP.0b013e32833fa7b3","volume":"21","author":"RJ Sevak","year":"2010","unstructured":"Sevak RJ, Stoops WW, Glaser PEAG, Hays LR, Rush CR (2010) Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Behav Pharmacol 21:745\u2013753","journal-title":"Behav Pharmacol"},{"key":"3449_CR62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02439595","volume":"93","author":"RB Smith","year":"1987","unstructured":"Smith RB, Kroboth PD (1987) Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects. Psychopharmacology 93:105\u2013112","journal-title":"Psychopharmacology"},{"key":"3449_CR63","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0269881104047281","volume":"18","author":"WW Stoops","year":"2004","unstructured":"Stoops WW, Glaser PEA, Fillmore MT, Rush CR (2004) Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 18:534\u2013543","journal-title":"J Psychopharmacol"},{"key":"3449_CR64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2007.03.016","volume":"87","author":"WW Stoops","year":"2007","unstructured":"Stoops WW, Vansickel AR, Lile JA, Rush CR (2007) Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav 87:20\u201329","journal-title":"Pharmacol Biochem Behav"},{"key":"3449_CR65","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (2012) Treatment Episode Data Set (TEDS): 2000\u20132010. State Admissions to Substance Abuse Treatment Services. DASIS Series S-63, HHS Publication No. (SMA) 12\u20134729. Rockville, MD"},{"key":"3449_CR66","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/appi.ajp.2011.11071121","volume":"169","author":"J Tiihonen","year":"2012","unstructured":"Tiihonen J, Krupitsky E, Verbitskaya E et al (2012) Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. Am J Psychiatry 169:531\u2013536","journal-title":"Am J Psychiatry"},{"key":"3449_CR67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02244190","volume":"104","author":"KA Trujillo","year":"1991","unstructured":"Trujillo KA, Belluzzi JD, Stein L (1991) Naloxone blockade of amphetamine place preference conditioning. Psychopharmacology 104:265\u2013274","journal-title":"Psychopharmacology"},{"key":"3449_CR68","unstructured":"United Nations Office of Drugs and Crime (2012) World Drug Report 2012. United Nations Vienna, pp 7 \u2013 9"},{"key":"3449_CR69","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M et al (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876\u2013880","journal-title":"Arch Gen Psychiatry"},{"key":"3449_CR70","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(25)21159-4","volume":"279","author":"SL Walsh","year":"1996","unstructured":"Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE (1996) Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther 279:524\u2013538","journal-title":"J Pharmacol Exp Ther"},{"key":"3449_CR71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.drugalcdep.2005.05.006","volume":"80","author":"EM Weerts","year":"2005","unstructured":"Weerts EM, Froestl W, Griffiths RR (2005) Effects of GABAergic modulators on food and cocaine self-administration in baboons. Drug Alcohol Depend 80:369\u2013376","journal-title":"Drug Alcohol Depend"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3449-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3449-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3449-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T17:02:58Z","timestamp":1746118978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3449-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,25]]},"references-count":71,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["3449"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3449-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,25]]}}}